Search

everythinglearnresearchcommunity

for

Search:↓

ODC expression in mouse skin and tumors is varied and can be inhibited by retinoic acid or cycloheximide.

Mutations in the hairless gene cause a rare form of permanent hair loss.

YAP1 is important for skin regeneration and may affect skin disorder treatments.

Non-coding RNA boosts retinoic acid production and signaling, aiding regeneration.

PON1 levels might indicate hair loss severity, but other health factors can affect this.

Researchers found a new genetic mutation linked to a hair condition in a Japanese boy.

Genetic testing for hairless gene mutations is crucial to correctly diagnose and treat atrichia with papular lesions.

Apocynin may protect skin cells from aging and damage caused by UVB light.

Inhibiting AP1 in mice skin causes structural changes and weakens the skin barrier.

The document did not conclude on apremilast's effectiveness for severe alopecia areata.

Agouti and AGRP affect pigmentation and obesity, with implications for metabolic disorders.

ApoBDs, once seen as waste, are now viewed as potential tools for disease treatment and tissue repair.

AP collagen peptides help hair grow and improve hair health.

The study found nine new hair protein genes in human hair follicles.

Higher CRBP1 levels are linked to more severe alopecia areata.

ODC1 gene mutations cause a neurodevelopmental disorder with large head size, hair loss, and facial abnormalities.

Congenital atrichia with papular lesions is often misdiagnosed, and new diagnostic criteria can improve accuracy.

Genetic testing confirmed a young girl has Atrichia with Papular Lesions due to mutations in the hairless gene.

Improved delivery systems can enhance oleanolic acid's effectiveness in treating various conditions.

ME1 and PPAR signaling may influence hair loss in androgenetic alopecia.

AP-2α and AP-2β proteins are essential for healthy adult skin and hair.

People with alopecia areata have higher levels of osteopontin, which might be important in the disease's development, but this doesn't relate to how severe the disease is.

Bald areas have lower cell growth, more DNA damage, and increased cell death.

Ishophloroglucin A from Ishige okamurae may be a natural alternative for treating hair loss by inhibiting 5α-reductase and promoting hair growth.

The MBTPS2 gene variant c.970+5G>A is a common mutation causing IFAP syndrome.

TRPS1 loss in balding scalp areas contributes to hair loss in androgenic alopecia.

IMG-007 helps regrow hair and reduce scalp inflammation in severe alopecia areata.

A 27-year-old with APS-1 showed improvement in symptoms after treatment.

Angiopoietin-1 helps hair follicle cells survive and grow, potentially treating hair loss.